|
|
Biography |
|
|
Hassan M. E. Azzazy, PhD, DABCC, FACB.
Dr. Azzazy is a tenured full professor of Chemistry (2003-present) at the American University in Cairo (AUC). He serves as the Chairman of Chemistry Department and was the Associate Dean for Graduate Studies & Research at the School of Sciences & Engineering, AUC. He is the director of the International Medical Laboratory Scientists training program at AUC.
Dr. Azzazy was a postdoctoral fellow and assistant professor at University of Maryland School of Medicine, Baltimore, MD (1995-2002). Dr. Azzazy is a graduate of Alexandria University, Egypt and received his PhD from the School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, TX (1994). He holds two board certifications in Clinical Chemistry and Molecular Diagnostics from the American Board of Clinical Chemistry, Washington, DC. He is certified as a Specialist in Chemistry by the Board of Certification, the American Society for Clinical Pathology in Chicago, IL.
Dr. Azzazy has over 27 years of experience in biomedical research and he is the founder of Novel Diagnostics and Therapeutics Research group. A core interest of this group is the development of innovative diagnostics for accurate and affordable detection of biomarkers of infectious agents and cancer. Detection strategies combine the use of nanosensors, chips, smart phones, 3D printers, and/or robotics. He is also interested in drug design, subcellular targeting of drugs using smart biodegradable nanocarriers, and development of biodegradable honey chitosan nanofibers for use as antibacterial wound dressings.
Dr. Azzazy authored over 85 scientific publications in international refereed journals, 70 conference presentations, and 25 book chapters. He serves on the editorial boards of Clinical Biochemistry (Elsevier), Clinica Chimica Acta (Elsevier), and Clinical Chemistry Laboratory Medicine (De Gruyter).
Dr. Azzazy has founded two nanomedicine startup companies. He is the recipient of numerous awards including State Prize in Advanced Technological Sciences (ASRT), Excellence in Research & Creative Endeavors Award (AUC), Global Innovator Award (Texas Christian University), and Arab Innovation & Entrepreneurship Award (ASTF, UAE).
|
|
|
|
|
|
|
Abstract |
|
|
|
|
Biosensors for Healthcare Applications |
|
|
|
|
|
Biosensors for Healthcare Applications.
Biosensors employ biological moieties for rapid and user-friendly detection and monitoring of disease biomarkers. Electrochemical and optical biosensors are used for metabolite and bioaffinity monitoring, respectively. The majority of commercial blood glucose meters are electrochemical biosensors which currently dominate the biosensor market (>$15B). Consumer demand and rising healthcare costs are expected to further drive the generation of low cost, wearable, and less-invasive biosensors to support maintenance of health, care of the elderly, drug testing, and medical diagnosis. This lecture will briefly introduce the basic structure of the biosensor, including the key biological moieties employed, and examples of recent biosensors. |
|
|
|
|